Related content

CD1 expression and CD1-restricted T cell activity in normal and tumour-bearing human liver

By Kenna Tony   O’Brien Margaret   Hogan Andrew   Exley Mark   Porcelli Steven   Hegarty John   O’Farrelly Cliona   Doherty Derek  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 4, 2007-04 ,pp. : 563-572

Springer Publishing Company

Access to resources Recommend Favorite

Analysis of naïve and memory CD4 and CD8 T cell populations in breast cancer patients receiving a HER2/neu peptide (E75) and GM-CSF vaccine

By Hueman Matthew   Stojadinovic Alexander   Storrer Catherine   Dehqanzada Zia   Gurney Jennifer   Shriver Craig   Ponniah Sathibalan   Peoples George  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 2, 2007-02 ,pp. : 135-146

Springer Publishing Company

Access to resources Recommend Favorite

Myeloid-derived suppressor cells suppress CD4+ and CD8+ T cell responses in autoimmune hepatitis

By              

Molecular Medicine Reports, Vol. 12, Iss. 3, 2015-01 ,pp. : 3667-3673

Spandidos Publications

Access to resources Recommend Favorite

CD4 and CD8 T cell responses to tumour-associated Epstein–Barr virus antigens in nasopharyngeal carcinoma patients

By Lin Xiaorong   Gudgeon Nancy   Hui Edwin   Jia Hui   Qun Xue   Taylor Graham   Barnardo Martin   Lin C.   Rickinson Alan   Chan Anthony  

Cancer Immunology, Immunotherapy, Vol. 57, Iss. 7, 2008-07 ,pp. : 963-975

Springer Publishing Company

Access to resources Recommend Favorite

Concomitant gemcitabine therapy negatively affects DC vaccine-induced CD8⁺ T-cell and B-cell responses but improves clinical efficacy in a murine pancreatic carcinoma model

By Bauer Christian   Sterzik Alexander   Bauernfeind Franz   Duewell Peter   Conrad Claudius   Kiefl Rosemarie   Endres Stefan   Eigler Andreas   Schnurr Max   Dauer Marc  

Cancer Immunology, Immunotherapy, Vol. 63, Iss. 4, 2014-04 ,pp. : 321-333

Springer Publishing Company

Access to resources Recommend Favorite